Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Mar;76(3):337–342. doi: 10.1136/jnnp.2004.036806

Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing

M Ramos-Arroyo 1, S Moreno 1, A Valiente 1
PMCID: PMC1739554  PMID: 15716522

Abstract

Background: Prior to the discovery of the Huntington's disease (HD) mutation, the prevalence, incidence, and new mutation rates for this disease were based on the presence of progressive choreic movements and a positive family history.

Objective: To evaluate the uptake of the HD genetic analysis in Spain, and to provide additional information on the epidemiology of this disease from the experience of 9 years of direct genetic testing.

Methods: From 1994 to 2002, CAG repeat length was determined in 317 patients with symptoms compatible with HD. In all cases, demographic, clinical, and family data were carefully reviewed.

Results: HD diagnosis (CAG repeat length ⩾36) was confirmed in 166 (52%) symptomatic cases. Of these, 76 (45.8%) reported a positive family history and in 21 cases (12.7%) family history was negative. New mutation events were genetically proven in three families and highly suspected in another, estimating that the minimum new mutation rate for HD in our population is >4%, with a potential mutation rate of 8%. More than 16% of all HD cases had late onset (>59 years) of symptoms, and in three quarters of these the family history was negative. The incidence rate for the autonomous communities of Navarra and the Basque country, based on the number of newly diagnosed cases by genetic testing, was 4.7 per million per year.

Conclusions: Direct HD genetic testing shows that the incidence and mutation rates of the disease are 2–3 times higher than previously reported. We also demonstrated the relevance of CAG repeat length assessment in diagnosing patients with late onset of symptoms and negative family history for HD.

Full Text

The Full Text of this article is available as a PDF (136.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almqvist E. W., Elterman D. S., MacLeod P. M., Hayden M. R. High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia. Clin Genet. 2001 Sep;60(3):198–205. doi: 10.1034/j.1399-0004.2001.600305.x. [DOI] [PubMed] [Google Scholar]
  2. Andrew S. E., Goldberg Y. P., Hayden M. R. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet. 1997 Nov;6(12):2005–2010. doi: 10.1093/hmg/6.12.2005. [DOI] [PubMed] [Google Scholar]
  3. Andrew S. E., Goldberg Y. P., Kremer B., Squitieri F., Theilmann J., Zeisler J., Telenius H., Adam S., Almquist E., Anvret M. Huntington disease without CAG expansion: phenocopies or errors in assignment? Am J Hum Genet. 1994 May;54(5):852–863. [PMC free article] [PubMed] [Google Scholar]
  4. Andrew S. E., Goldberg Y. P., Kremer B., Telenius H., Theilmann J., Adam S., Starr E., Squitieri F., Lin B., Kalchman M. A. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet. 1993 Aug;4(4):398–403. doi: 10.1038/ng0893-398. [DOI] [PubMed] [Google Scholar]
  5. Burguera J. A., Solís P., Salazar A. Estimación de la prevalencia de la enfermedad de Huntington por el método de captura-recaptura en la Comunidad Valenciana. Rev Neurol. 1997 Dec;25(148):1845–1847. [PubMed] [Google Scholar]
  6. Calcedo Ordóez A. Enfermedad de Huntington en la provincia de Cádiz. Estudio epidemiológico y familiar. Rev Clin Esp. 1970 Dec 30;119(4):333–344. [PubMed] [Google Scholar]
  7. Conneally P. M. Huntington disease: genetics and epidemiology. Am J Hum Genet. 1984 May;36(3):506–526. [PMC free article] [PubMed] [Google Scholar]
  8. Falush D., Almqvist E. W., Brinkmann R. R., Iwasa Y., Hayden M. R. Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. Am J Hum Genet. 2001 Feb;68(2):373–385. doi: 10.1086/318193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldberg Y. P., Kremer B., Andrew S. E., Theilmann J., Graham R. K., Squitieri F., Telenius H., Adam S., Sajoo A., Starr E. Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects. Nat Genet. 1993 Oct;5(2):174–179. doi: 10.1038/ng1093-174. [DOI] [PubMed] [Google Scholar]
  10. Harper P. S., Lim C., Craufurd D. Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium. J Med Genet. 2000 Aug;37(8):567–571. doi: 10.1136/jmg.37.8.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harper P. S. The epidemiology of Huntington's disease. Hum Genet. 1992 Jun;89(4):365–376. doi: 10.1007/BF00194305. [DOI] [PubMed] [Google Scholar]
  12. James C. M., Houlihan G. D., Snell R. G., Cheadle J. P., Harper P. S. Late-onset Huntington's disease: a clinical and molecular study. Age Ageing. 1994 Nov;23(6):445–448. doi: 10.1093/ageing/23.6.445. [DOI] [PubMed] [Google Scholar]
  13. Kokmen E., Ozekmekçi F. S., Beard C. M., O'Brien P. C., Kurland L. T. Incidence and prevalence of Huntington's disease in Olmsted County, Minnesota (1950 through 1989). Arch Neurol. 1994 Jul;51(7):696–698. doi: 10.1001/archneur.1994.00540190076018. [DOI] [PubMed] [Google Scholar]
  14. MacMillan J. C., Davies P., Harper P. S. Molecular diagnostic analysis for Huntington's disease: a prospective evaluation. J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):496–498. doi: 10.1136/jnnp.58.4.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mandich P., Di Maria E., Bellone E., Ajmar F., Abbruzzese G. Molecular analysis of the IT15 gene in patients with apparently 'sporadic' Huntington's disease. Eur Neurol. 1996;36(6):348–352. doi: 10.1159/000117292. [DOI] [PubMed] [Google Scholar]
  16. Sánchez A., Milà M., Castellví-Bel S., Calopa M., Genís D., Jiménez D., Estivill X. Análisis molecular del gen IT15 en 79 familias españolas afectadas de enfermedad de Huntington: confirmación diagnóstica y diagnóstico presintomático. Med Clin (Barc) 1997 May 10;108(18):687–690. [PubMed] [Google Scholar]
  17. Warner J. P., Barron L. H., Brock D. J. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes. 1993 Jun;7(3):235–239. doi: 10.1006/mcpr.1993.1034. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES